CANLI
Yükleniyor Veriler getiriliyor…
/ Atıflar / Detay

Atıf Detayı

Kurum makalesi · Scopus üzerinden alınan atıf kaydı

Kurumun Atıf Alan Makalesi
Atıf Alan Yayın
Screening of in vitro antioxidant and enzyme inhibitory activities of different extracts from two uninvestigated wild plants: Centranthus longiflorus subsp. longiflorus and Cerinthe minor subsp. auriculata
European Journal of Integrative Medicine Cilt 8 ss. 286-292
Scopus Toplam 130 atıf DOI
Introduction The importance of plants products in traditional medicine has been recognized for some time. Two plants of Turkish origin, Centranthus longiflorus subsp. longiflorus and Cerinthe minor subsp. auriculata used as traditional Turkish medicine have remained uninvestigated for Alzheimer diseases and diabetes mellitus for their in vitro biological activity despite their use for sleep disorders. The antioxidant and enzyme inhibitory properties of these plants have not been reported. The aim of this study was to determine the total phenolics, flavonoids, and antioxidant as well as their enzyme inhibitory activity (in aqueous and solvent extracts). Methods Antioxidant assays used standard methods to assess phosphomolybdenum, free radical scavenging activity, reducing power, and metal chelating activity on ferrous ions. Additionally, the extracts were tested also for enzyme inhibitory activity (Cholinesterase, Tyrosinase, α-amylase, and α-glucosidase). Results Organic extracts showed the highest anti-cholinesterase (AChE, and BChE) activity, while aqueous extracts showed valuable Tyrosinase inhibitory activity. Total phenolics (expressed as gallic acid equivalents) in C. longiflorus subsp. longiflorus and C. minor subsp. auriculata were 46.2 and 25.4 mg in methanolic extracts, 27.5 and 26.2 mg in ethyl acetate extracts, and 37.9 and 46.6 mg in aqueous extracts, respectively. Similarly, total flavonoids (expressed as rutin equivalents) in C. longiflorus subsp. longiflorus and C. minor subsp. auriculata were 39.9 and 27.8 mg in methanolic extracts, 17.6 and 52.4 mg in ethyl acetate extracts, and 24.35 and 24.6 mg in aqueous extracts, respectively. Conclusion The reported results may be valuable for preparing new food supplements and can represent a good model for the development of new drug formulations.
Atıf Kaynağı
Atıf Yapan Yayın
UHPLC-MS/MS-guided profiling and bioactivity screening of Papaver apokrinomenon extracts: Insights into alkaloid- and phenolic-driven health effects
Fitoterapia Cilt 187
Scopus Havuzumuzda 2 atıf almış
Papaver species are widely known for their remarkable ability to produce a diverse array of secondary metabolites, notably alkaloids. Among them, P. apokrinomenon stands out as a significant species, yet its chemical profile and biological activities remain unexplored. To address this, extracts using ethyl acetate, ethanol, and a 70/30 ethanol-water mixture were generated through methods such as Homogenizer-assisted extraction (HAE), Maceration (MAC), and Ultrasound-assisted extraction (UAE). Various in vitro assays, namely DPPH, ABTS, FRAP, CUPRAC, PBD, and metal chelation tests, were utilized for assessing the antioxidant capabilities of these extracts. Furthermore, the extracts of P. apokrinomenon were analyzed for their inhibitory effects on enzymes like cholinesterases (AChE, BChE), tyrosinase, and those involved in diabetes (α-amylase and α-glucosidase). UHPLC-MS/MS analysis detected several alkaloids, including salsolinol, salutaridinol, norcoclaurine, and salutaridine, within the extracts. Findings indicated that the extracts from both 70 % ethanol and ethanol (extracted via MAC and UAE) demonstrated superior radical scavenging, reduction potential, and overall antioxidant function. Moreover, all extraction methods yielded 70 % ethanol and ethanol extracts that showed strong enzyme inhibitory activities across the board. Supporting in silico analyses, such as structure-based docking against AChE, BChE, α-amylase, and α-glucosidase, complemented by 100 ns MD simulations and MM/GBSA calculations, indicated favorable binding energies for pivotal alkaloids against each enzyme, aligning qualitatively with the in vitro enzyme inhibition. These findings propose that P. apokrinomenon could be promising for traditional medicine use and hold potential for development into natural health products, targeting various pharmaceutical-related therapies.
Atıf Yapan Makale Bilgileri
Kurumlar (3)
Harran Üniversitesi Sanliurfa, Turkey
Selçuk Üniversitesi Selçuklu, Turkey
University of Nyíregyháza Nyíregyháza, Hungary